首页> 外国专利> METHOD OF PRODUCTION OF CYTOKINE INDUCED/ACTIVATED KILLER CELLS FROM PERIPHERIAL BLOOD, BONE MARROW OR APHERESIS PRODUCT AND USE THEREOF

METHOD OF PRODUCTION OF CYTOKINE INDUCED/ACTIVATED KILLER CELLS FROM PERIPHERIAL BLOOD, BONE MARROW OR APHERESIS PRODUCT AND USE THEREOF

机译:从外周血,骨骼或运动产物生产细胞因子诱导/活化的杀伤细胞的方法及其用途

摘要

The invention relates to the field of medicine, in particular to the isolation of cytokine induced killer cells from peripheral blood, bone marrow or apheresis product, their activation, proliferation and use in immunotherapy to destroy or reduce the oncological or metastasization processes, thus preventing the formation of novel tumour derivatives, by using the patient’s own killer cells and their immunologically active proteins. Peripheral blood or blood apheresis product or bone marrow aspirate is separated by isolating only mononuclear cell fraction, said fraction is plated in a cell culture medium on a special bioreactor for 17-20 days. By growing the cells in a bioreactor, glucose consumption is measured, and it reflects the cell growth activity and shows the time when it is possible to stop production and collect cells for freezing and further use. The medium is decanted, cells are collected, counted and frozen at 0.5-5.0 bn. cells in a cells freezing medium with an autologous patient’s serum.
机译:本发明涉及医学领域,尤其涉及从外周血,骨髓或血液分离产物中分离细胞因子诱导的杀伤细胞,它们的活化,增殖以及在免疫疗法中用于破坏或减少肿瘤或转移过程,从而防止肿瘤的发生。通过使用患者自身的杀伤细胞及其免疫活性蛋白形成新的肿瘤衍生物。通过仅分离单核细胞级分来分离外周血或血液单采产品或骨髓抽吸物,将所述级分铺在特殊生物反应器上的细胞培养基中17-20天。通过使细胞在生物反应器中生长,可以测量葡萄糖消耗,它反映了细胞的生长活性,并显示了可以停止生产并收集细胞以进行冷冻和进一步使用的时间。倒出培养基,收集细胞,计数并冷冻至0.5-5.0亿。含有自体患者血清的细胞冷冻培养基中的细胞。

著录项

  • 公开/公告号LT6677B

    专利类型

  • 公开/公告日2019-11-11

    原文格式PDF

  • 申请/专利权人 DARINSKAS ADAS;

    申请/专利号LT20190000512

  • 发明设计人 DARINSKAS ADAS;

    申请日2019-04-18

  • 分类号C12N5;A61K35;

  • 国家 LT

  • 入库时间 2022-08-21 11:17:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号